Institutional Ownership Cytokinetics Inc (CYTK)
This table provides information about the institutional ownership of Cytokinetics Inc (CYTK). We have compiled data on the 405 institutions that hold shares in the stock, with a total of 125 Million shares, which have been reported (via 13F filing form) to have a value of $6.24 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,672,779
shares
|
$726 Million
0.02% of portfolio
|
Q2 2024
Added 18.19%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
11,761,605
shares
|
$582 Million
0.01% of portfolio
|
Q3 2024
Added 2.83%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
9,689,987
shares
|
$479 Million
0.31% of portfolio
|
Q3 2024
Added 19.06%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
7,774,970
shares
|
$385 Million
0.07% of portfolio
|
Q3 2024
Added 3.53%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
6,458,324
shares
|
$319 Million
0.01% of portfolio
|
Q3 2024
Reduced 1.38%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
4,829,423
shares
|
$239 Million
0.02% of portfolio
|
Q3 2024
Added 10.24%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,164,945
shares
|
$157 Million
0.02% of portfolio
|
Q3 2024
Added 34.2%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,848,584
shares
|
$141 Million
0.01% of portfolio
|
Q3 2024
Added 4.01%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,721,158
shares
|
$135 Million
2.29% of portfolio
|
Q2 2024
Added 7.77%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
2,337,847
shares
|
$116 Million
0.76% of portfolio
|
Q3 2024
Reduced 4.76%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,252,206
shares
|
$111 Million
0.09% of portfolio
|
Q2 2023
Reduced 0.8%
|
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
2,100,000
shares
|
$104 Million
5.89% of portfolio
|
Q4 2020
New holding
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 12, 2024 Q3 2024 |
2,088,567
shares
|
$103 Million
0.13% of portfolio
|
Q3 2024
Added 18.12%
|
|
|
Armistice Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,896,575
shares
|
$93.8 Million
1.66% of portfolio
|
Q3 2024
Reduced 8.2%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
1,873,701
shares
|
$92.7 Million
0.13% of portfolio
|
Q3 2024
Added 11.65%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,757,192
shares
|
$86.9 Million
5.44% of portfolio
|
Q4 2023
Reduced 26.77%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,661,014
shares
|
$82.2 Million
0.03% of portfolio
|
Q3 2024
Reduced 11.61%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,500,000
shares
|
$74.2 Million
6.01% of portfolio
|
Q3 2024
Reduced 27.71%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,329,654
shares
|
$65.8 Million
0.01% of portfolio
|
Q3 2024
Added 3.64%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,321,391
shares
|
$65.4 Million
0.01% of portfolio
|
Q3 2024
Added 42.75%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
1,234,917
shares
|
$61.1 Million
0.01% of portfolio
|
Q3 2024
Added 11.06%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,212,886
shares
|
$60 Million
0.3% of portfolio
|
Q3 2024
Added 38.85%
|
|
|
Melqart Asset Management (Uk) LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
1,212,258
shares
|
$60 Million
6.24% of portfolio
|
Q3 2024
Reduced 27.66%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,184,789
shares
|
$58.6 Million
0.01% of portfolio
|
Q3 2024
Added 4.1%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,168,372
shares
|
$57.8 Million
0.0% of portfolio
|
Q3 2024
Added 5.67%
|